Skip to main content
. 2020 Dec 2;10:580112. doi: 10.3389/fonc.2020.580112

Figure 6.

Figure 6

Survival of de novo bone metastatic patients in different nomogram-based risk groups according to primary surgery. (A, D) OS and BCSS in nomogram-based low-risk group; (B, E) OS and BCSS in nomogram-based intermediate-risk group; (C, F) OS and BCSS in nomogram-based high-risk group.